RPAM
VRNA

Rhenman & Partners Asset Management’s Verona Pharma VRNA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$10.1M Buy
106,500
+36,500
+52% +$3.45M 1.27% 32
2025
Q1 		$4.44M Buy
+70,000
New +$4.44M 0.51% 48